QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

23,585 signal articles · 321 in last 24h · 112,405 total before filter · latest 1h ago
321last 24h
2134last 7d
379● bullish (7d)
186● bearish (7d)
204publishers
AllMacro296Earnings1213M&A90Regulatory23Product13Analyst20
✕ clear all filtersticker: CVSsentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
CVS Stock Rises Near Buy Point On Hearty Earnings Checkup
Investor's Business Daily7d agobullish
CVS Stock Rises Near Buy Point On Hearty Earnings Checkup

CVS Health earnings surged past tepid forecasts after reporting its health benefit costs fell as a share of premiums. The pharmacy chain hiked its full-year outlook by a bit less than the Q2 beat. Analysts say that management's prudence in trying to grow its health benefits business let the company avoid the worst fallout from surprisingly strong medical care utilization.

UnitedHealth stock jumps on Q2 earnings, raises full-year outlook
Yahoo Finance Video27d agobullishVIDEO
UnitedHealth stock jumps on Q2 earnings, raises full-year outlook

Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.

UNH Stock Flashes Buy Signal On Massive Earnings Beat
Investor's Business Daily27d agobullish
UNH Stock Flashes Buy Signal On Massive Earnings Beat

UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook. Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.

UNH, CVS Lead S&P 500 Health Insurers Flashing Buy Signals
Investor's Business Daily69d agobullish
UNH, CVS Lead S&P 500 Health Insurers Flashing Buy Signals

UnitedHealth Group, CVS Health and other S&P 500 health insurance giant rallied on Thursday morning after price-target hikes from Morgan Stanley and a UNH upgrade from BofA. The analysts highlighted moderating health care utilization trends and a tailwind to profitability from deploying AI.

A Look At CVS Health (CVS) Valuation After Earnings Beat And Raised 2026 Guidance
Simply Wall St.93d agobullish
A Look At CVS Health (CVS) Valuation After Earnings Beat And Raised 2026 Guidance

CVS Health (CVS) is back in focus after first quarter 2026 results and raised full year guidance, with management highlighting broad based strength across Aetna, Health Services, and Pharmacy & Consumer Wellness. See our latest analysis for CVS Health. After the earnings beat and guidance raise, the share price has climbed to US$90.55, with a 1 month share price return of 14.14% and a 1 year total shareholder return of 44.83%. This suggests momentum has picked up recently compared with longer...

More Record Highs — Heard on the Street Wednesday Recap
The Wall Street Journal98d agobullish
More Record Highs — Heard on the Street Wednesday Recap

Oil prices fell and stocks rose on rising optimism about an end to Middle East hostilities. Iran and the U.S. are working with mediators on a one-page framework to restart negotiations aimed at ending the conflict and opening the Strait of Hormuz, with talks potentially beginning next week in Islamabad. Semiconductor stocks extended their rally.

CVS Health tops Q1 estimates, raises full-year guidance
Proactive98d agobullish
CVS Health tops Q1 estimates, raises full-year guidance

CVS Health Corp (NYSE:CVS) shares rose about 6% on Wednesday morning after the retail pharmacy chain reported first quarter financial results that topped Wall Street expectations on both earnings and revenue. The company posted adjusted earnings per share (EPS) of $2.57, compared with analyst...